AMI Organics

₹1274.9 34.5 | 2.8%

WEBSITE BSE:543349 NSE : AMIORG 09 Jun, 14:16

Market Cap ₹4646 Cr.

Stock P/E 55.6

P/B 7.8

Current Price ₹1274.9

Book Value ₹ 163

Face Value 10

52W High ₹1258

Dividend Yield 0.24%

52W Low ₹ 826

Edit Ratio

AMI Organics Research see more...

Ami Organics Ltd

Overview Inc. Year: 2007Industry: Pharmaceuticals & Drugs

Ami Organics Ltd engages in the R&D, manufacture, and sale of pharmaceutical intermediates in India. The enterprise offers about 450 pharma intermediates to be used in regulated and generic active pharmaceutical components for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-parkinson, anti-depressant, and anti-coagulant packages, in addition to new chemical entities. It additionally offers preservatives, such as parabens and parabens formulations for use in cosmetics, animal meals, and personal care industries; and specialty chemicals for use in cosmetics, dyes, polymers, and agrochemicals. In addition, the company exports its products to approximately 25 nations worldwide. Ami Organics Ltd founded in 2004 and is based in Surat, India.

AMI Organics Share Price

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

AMI Organics Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023
Net Sales	122	141	144	131	147	152	186
Other Income	0	1	0	1	1	3	-0
Total Income	122	143	144	132	148	155	186
Total Expenditure	95	111	118	108	119	122	146
Operating Profit	28	31	26	24	29	34	41
Interest	3	0	1	0	0	1	1
Depreciation	2	2	3	3	3	3	3
Exceptional Income / Expenses	0	0	0	0	0	0	0
Profit Before Tax	23	29	22	20	26	30	37
Provision for Tax	5	9	1	5	7	7	9
Profit After Tax	17	19	21	15	19	22	27
Adjustments	-0	0	0	-0	0	0	0
Profit After Adjustments	17	19	21	15	19	22	27
Adjusted Earnings Per Share	4.8	5.3	5.8	4.1	5.2	6.1	7.5

AMI Organics Profit & Loss

#(Fig in Cr.)	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	TTM
Net Sales	154	160	188	239	240	341	520	616
Other Income	3	0	3	0	3	1	3	5
Total Income	157	160	191	239	242	342	523	621
Total Expenditure	136	137	158	196	199	260	415	495
Operating Profit	21	23	33	42	44	82	108	128
Interest	3	3	3	5	6	6	6	2
Depreciation	1	1	2	3	4	4	10	12
Exceptional Income / Expenses	0	0	0	0	0	0	0	0
Profit Before Tax	18	19	28	35	35	72	91	113
Provision for Tax	5	7	10	12	7	18	20	28
Profit After Tax	13	12	18	23	27	54	72	83
Adjustments	0	0	0	0	0	0	0	0
Profit After Adjustments	13	12	18	23	27	54	72	83
Adjusted Earnings Per Share	0	0	0	0	0	5.7	19.7	22.9

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	52%	30%	27%	0%
Operating Profit CAGR	32%	37%	36%	0%
PAT CAGR	33%	46%	43%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	34%	NA%	NA%	NA%
ROE Average	21%	30%	32%	35%
ROCE Average	24%	28%	31%	32%

AMI Organics Balance Sheet

#(Fig in Cr.)	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Shareholder's Funds	27	39	58	82	112	167	522
Minority's Interest	0	0	0	0	0	0	0
Borrowings	16	15	32	22	20	73	1
Other Non-Current Liabilities	-1	1	1	3	6	8	7
Total Current Liabilities	49	55	65	106	95	166	129
Total Liabilities	91	109	155	213	232	413	659
Fixed Assets	18	28	32	79	85	186	205
Other Non-Current Assets	6	15	35	10	26	5	19
Total Current Assets	66	66	87	124	121	216	429
Total Assets	91	109	155	213	232	413	659

AMI Organics Cash Flow

#(Fig in Cr.)	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Opening Cash & Cash Equivalents	0	0	3	1	0	4	3
Cash Flow from Operating Activities	10	29	8	15	27	28	-9
Cash Flow from Investing Activities	-14	-19	-25	-21	-24	-101	-124
Cash Flow from Financing Activities	4	-7	15	6	0	72	140
Net Cash Inflow / Outflow	-0	3	-2	-0	3	-1	8
Closing Cash & Cash Equivalent	0	3	1	0	4	3	10

AMI Organics Ratios

#	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Earnings Per Share (Rs)	0	0	0	0	0	5.71	19.75
CEPS(Rs)	4.27	4.26	6.48	8.22	9.84	6.16	22.51
DPS(Rs)	0	0	0	0	0	0	3
Book NAV/Share(Rs)	0	0	0	0	0	17.01	141.51
Core EBITDA Margin(%)	11.83	14.43	16.21	17.64	17.12	23.53	20.22
EBIT Margin(%)	13.18	13.71	16.77	16.71	16.83	22.71	18.81
Pre Tax Margin(%)	11.52	11.66	15.06	14.72	14.5	21.06	17.58
PAT Margin (%)	8.23	7.52	9.83	9.77	11.46	15.85	13.83
Cash Profit Margin (%)	8.75	8.37	10.84	10.86	12.93	17.08	15.77
ROA(%)	13.87	12.04	13.99	12.64	12.34	16.74	13.42
ROE(%)	46.43	36.44	39.03	33.73	28.31	39.63	21.28
ROCE(%)	35.54	35.91	38.24	33.8	26.25	33.01	24.05
Receivable days	86.2	82.89	83.83	96.45	100.9	94.89	99.79
Inventory Days	46.64	44.82	45.68	50.54	69.31	60.39	60.54
Payable days	113.37	128.43	139.26	142.81	169.65	138.36	135.92
PER(x)	0	0	0	0	0	0	50.63
Price/Book(x)	0	0	0	0	0	0	7.06
Dividend Yield(%)	0	0	0	0	0	0	0.3
EV/Net Sales(x)	0.2	0.15	0.23	0.27	0.28	0.49	6.81
EV/Core EBITDA(x)	1.46	1.05	1.32	1.51	1.51	2.03	32.83
Net Sales Growth(%)	0	4.27	17.45	26.72	0.47	42.13	52.71
EBIT Growth(%)	0	8.48	43.65	26.26	1.2	91.73	26.52
PAT Growth(%)	0	-4.8	53.51	25.95	17.92	96.57	33.24
EPS Growth(%)	0	0	0	0	0	-34.47	245.55
Debt/Equity(x)	1.09	0.68	0.78	0.66	0.53	0.85	0
Current Ratio(x)	1.36	1.21	1.34	1.18	1.28	1.3	3.32
Quick Ratio(x)	0.96	0.85	0.92	0.81	0.73	0.94	2.45
Interest Cover(x)	7.92	6.67	9.79	8.39	7.22	13.77	15.27
Total Debt/Mcap(x)	0	0	0	0	0	0	0

AMI Organics Shareholding Pattern

#	Sep 2015	Aug 2016	May 2018	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023
Promoter	100	98.33	81	41.05	41.05	41.05	41.05	39.41	39.41	39.41
FII	0	0	0	3.64	1.34	2.23	1.84	5.76	6.41	6.36
DII	0	0	0	9.49	3.81	5.63	4.19	3.61	3.72	3.63
Public	0	1.67	19	45.81	53.8	51.08	52.91	51.22	50.46	50.6
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Sep 2015	Aug 2016	May 2018	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023
Promoter	0.15	0.15	0.85	1.5	1.5	1.5	1.5	1.44	1.44	1.44
FII	0	0	0	0.13	0.05	0.08	0.07	0.21	0.23	0.23
DII	0	0	0	0.35	0.14	0.21	0.15	0.13	0.14	0.13
Public	0	0	0.2	1.67	1.96	1.86	1.93	1.87	1.84	1.84
Others	0	0	0	0	0	0	0	0	0	0
Total	0.15	0.15	1.05	3.64	3.64	3.64	3.64	3.64	3.64	3.64

Pros

Company has delivered good profit growth of 43% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 30%
Debtor days have improved from 138.36 to 135.92days.
Company has reduced debt.
Company is almost debt free.

Cons

Promoter holding is low: 39.41%.
Stock is trading at 7.8 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.